These days, I find myself using some of the same words to describe Parkinson’s as I do to describe the experience of physicians like me who treat patients with the disease. It’s a sad reflection on current health insurer practices.
Add movement disorders patients to the long list of people whose health could suffer under the Trump administration’s proposal to loosen Medicare protections on six classes of medications for high-risk diseases.
An upcoming meeting will give people with movement disorders a chance to tell Food and Drug Administration regulators their story – the story of their physical symptoms as well as their emotional ones.
Men and women with a co-occurring movement disorder and mental illness experience painful stigma. Fear, shame and isolation hurt them, their families and their communities. Stigma also keeps people from seeking treatment.
Last month, the federal government proposed changes to Medicare’s billing rules. The net effect: Doctors will spend less time with their patients. As a physician myself, I know that’s not necessarily a good thing.
An influential calculation of how new drugs impact annual spending is flawed – and patients may be paying the price in reduced access to innovative medicine.
It's not easy to tell the world you're "different." Katie Wilson, from Broomfield, wants to have a conversation about her Tourette Syndrome with anyone who's willing to truly listen.